Cargando…
Effects of dexamethasone on immune dysfunction and ventilator-associated pneumonia in COVID-19 acute respiratory distress syndrome: an observational study
Dexamethasone improves survival of patients with COVID-19 acute respiratory distress syndrome, but might shorten the delay between the start of invasive mechanical ventilation and the occurrence of ventilator-associated pneumonia, suggesting possible worsening of COVID-19-induced immune dysfunction...
Autores principales: | Cour, Martin, Simon, Marie, Argaud, Laurent, Monneret, Guillaume, Venet, Fabienne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522132/ https://www.ncbi.nlm.nih.gov/pubmed/34663481 http://dx.doi.org/10.1186/s40560-021-00580-6 |
Ejemplares similares
-
Coronavirus disease 2019 as a particular sepsis: a 2-week follow-up of standard immunological parameters in critically ill patients
por: Monneret, Guillaume, et al.
Publicado: (2020) -
Intracellular calcium signaling and phospho-antigen measurements reveal functional proximal TCR activation in lymphocytes from septic shock patients
por: de Roquetaillade, Charles, et al.
Publicado: (2019) -
Longitudinal assessment of IFN-I activity and immune profile in critically ill COVID-19 patients with acute respiratory distress syndrome
por: Venet, Fabienne, et al.
Publicado: (2021) -
Airway Closure and Expiratory Flow Limitation in Acute Respiratory Distress Syndrome
por: Guérin, Claude, et al.
Publicado: (2022) -
Clinical review: flow cytometry perspectives in the ICU - from diagnosis of infection to monitoring of injury-induced immune dysfunctions
por: Venet, Fabienne, et al.
Publicado: (2011)